Fidaxomicin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Fidaxomicin Product Information
Fidaxomicin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Fidaxomicin. The product is supplied by Clearsynth under CAT No. CS-O-30824.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Fidaxomicin
CAS No.
873857-62-6
CAT No.
CS-O-30824
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C52H74Cl2O18
Molecular Weight
1058.04
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Fidaxomicin is supplied with detailed characterization data compliant with regulatory guideline. Fidaxomicin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Fidaxomicin.
Overview
"Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen."
"Babakhani; F,; et al,:clin, Infct, Dis,; 55; S162 (2012); Venugopal; A,; et al,:clin, Infct, Dis,; 54; 568 (2012)"
Synonyms
Fidaxomicin
Application Notes
"Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen."
"Babakhani; F,; et al,:clin, Infct, Dis,; 55; S162 (2012); Venugopal; A,; et al,:clin, Infct, Dis,; 54; 568 (2012)"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.